CERo Therapeutics Holdings, Inc.
CERO
$9.46
$0.232.49%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.20M | 3.25M | 3.38M | 3.65M | 4.59M |
| Total Receivables | -- | -- | -- | 87.40K | 162.10K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 564.50K | 274.70K | 334.30K | 511.50K | 746.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 187.00K | -- | -- | -- |
| Total Current Assets | 5.77M | 3.71M | 3.71M | 4.25M | 5.50M |
|
|
|||||
| Total Current Assets | 5.77M | 3.71M | 3.71M | 4.25M | 5.50M |
| Net Property, Plant & Equipment | 1.72M | 1.99M | 2.28M | 2.57M | 2.87M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 500.00K | 500.00K | 500.00K | 550.00K | 683.30K |
| Total Assets | 7.99M | 6.21M | 6.49M | 7.37M | 9.05M |
|
|
|||||
| Total Accounts Payable | 6.38M | 4.51M | 6.67M | 6.35M | 7.06M |
| Total Accrued Expenses | 469.70K | 1.91M | 1.69M | 1.16M | 294.30K |
| Short-term Debt | -- | -- | 102.30K | 253.20K | 402.50K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 905.00K | 876.40K | 931.00K | 821.30K | 794.90K |
| Total Finance Division Other Current Liabilities | 105.50K | 105.50K | 30.00K | 200.00K | 3.10M |
| Total Other Current Liabilities | 105.50K | 105.50K | 30.00K | 200.00K | 3.10M |
| Total Current Liabilities | 7.86M | 7.40M | 9.42M | 8.78M | 11.65M |
|
|
|||||
| Total Current Liabilities | 7.86M | 7.40M | 9.42M | 8.78M | 11.65M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | 102.30K | 253.20K | 402.50K |
| Capital Leases | 461.60K | 699.10K | 771.50K | 1.07M | 1.37M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 13.70K |
| Total Liabilities | 8.32M | 8.10M | 10.19M | 9.85M | 13.03M |
|
|
|||||
| Common Stock & APIC | 73.35M | 67.14M | 66.38M | 57.64M | 54.00M |
| Retained Earnings | -76.02M | -70.92M | -71.59M | -67.36M | -64.91M |
| Treasury Stock & Other | -78.80K | -1.30M | -2.07M | -2.20M | -2.50M |
| Total Common Equity | -2.76M | -5.07M | -7.29M | -11.92M | -13.42M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 2.43M | 3.18M | 3.58M | 9.44M | 9.44M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 2.43M | 3.18M | 3.58M | 9.44M | 9.44M |
|
|
|||||
| Total Common Equity | -2.76M | -5.07M | -7.29M | -11.92M | -13.42M |
| Total Preferred Equity | 2.43M | 3.18M | 3.58M | 9.44M | 9.44M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -329.40K | -1.89M | -3.70M | -2.48M | -3.98M |
|
|
|||||